Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,969 | 16,537 | 63,788 | 47,022 | 35,675 |
| Depreciation Amortization | 10,786 | 5,084 | 20,395 | 15,524 | 10,365 |
| Income taxes - deferred | -4,918 | 2,547 | -2,749 | -4,218 | -5,026 |
| Accounts payable and accrued liabilities | -3,310 | -1,718 | -428 | -2,357 | -1,171 |
| Other Working Capital | -16,096 | -11,493 | -27,999 | -27,781 | -28,584 |
| Other Operating Activity | 12,242 | 6,726 | 17,634 | 16,428 | 11,125 |
| Operating Cash Flow | $25,673 | $17,683 | $70,641 | $44,618 | $22,384 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,869 | -3,198 | -14,479 | -7,157 | -5,703 |
| Other Investing Activity | 255 | -870 | 2,504 | 2,504 | 2,504 |
| Investing Cash Flow | $-5,614 | $-4,068 | $-11,975 | $-4,653 | $-3,199 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 691 | 537 | 1,542 | 750 | 750 |
| Common Stock Repurchased | -9,444 | -9,444 | -11,599 | -11,599 | 0 |
| Other Financing Activity | -4,546 | -3,039 | -4,180 | -4,046 | -4,004 |
| Financing Cash Flow | $-13,299 | $-11,946 | $-14,237 | $-14,895 | $-3,254 |
| Exchange Rate Effect | -4,831 | -3,809 | -2,503 | -6,567 | -4,310 |
| Beginning Cash Position | 333,246 | 333,246 | 291,320 | 291,320 | 291,320 |
| End Cash Position | 335,175 | 331,106 | 333,246 | 309,823 | 302,941 |
| Net Cash Flow | $1,929 | $-2,140 | $41,926 | $18,503 | $11,621 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,673 | 17,683 | 70,641 | 44,618 | 22,384 |
| Capital Expenditure | -5,872 | -3,201 | -14,494 | -7,170 | -5,716 |
| Free Cash Flow | 19,801 | 14,482 | 56,147 | 37,448 | 16,668 |